Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sensoril for Cognitive Enhancement in Bipolar Disorder
NCT00761761Phase 3Completed
- Sponsor
- University of Pittsburgh
- Start
- Oct 2008
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of withania somnifera in bipolar disorder (BD), sponsored by University of Pittsburgh. Started Oct 2008; status: completed.
02
Drugs
withania somnifera
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00761761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00761761.